Research and Development

In the face of restricted budgets, payers worldwide are increasingly using Health Technology Assessments (HTAs) as a way of managing …

Most treatments for ADHD are stimulants, while the two most common treatments Adderall and Ritalin contain amphetamines. Due to the …

Collegium Pharmaceutical has announced the appointment of Joseph Ciaffoni to the position of Executive Vice President and Chief Operating Officer. …

Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …

The FDA has given its approval for the commercialisation of the first-ever generic versions of Eli Lilly’s Strattera (atomoxetine) for …

Roche, the supplier of Valium in Australia, had notified the Therapeutic Goods Administration (TGA) that it had discovered evidence of …

Novartis has revealed that increasing pressure on pricing in the US has impacted its second-quarter business, cutting into sales generated …

There were fears in Ireland that President Trump’s strong words to bring manufacturing back to the US would hurt the …

Scientists at The Scripps Research Institute (TSRI) have succeeded in reengineering vancomycin – a widely-used antibiotic – in order to …

Bristol-Myers Squibb and Array BioPharma have announced they are to join forces as part of a new clinical research partnership …

New research from the University of Leeds has called into question the prevalent practice of prescribing beta blockers for heart …

Gene-editing has been heralded as a wonder tool which could lead to huge advances in a wide range of treatment …

London, May 30, 2017 – Global Pricing Innovations (GPI), the pricing and intelligence experts for the life sciences industry and …

Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …

Among other things, it’s been a week characterised by safety failures as three of our most popular stories centred on …